New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
06:00 EDTBG, SZYMSolazyme Bunge renewable oils plant begins commercial production in Brazil
Solazyme (SZYM) announced that its joint venture with Bunge Global Innovation, a wholly-owned subsidiary of Bunge (BG), has successfully produced its first commercially saleable products on full-scale production lines, including the 625,000L fermentation tanks, at the Solazyme Bunge Renewable Oils plant in Brazil. Both oil and encapsulated lubricant, Encapso, products have been manufactured; production is continuing and is expected to reach nameplate capacity within the next 12-18 months.
News For SZYM;BG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
16:23 EDTSZYMSolazyme reports Q4 EPS (57c), consensus (47c)
Reports Q4 revenue $14.5M, consensus $17.7M.
February 25, 2015
05:11 EDTSZYMSolazyme receives FDA GRAS No Questions Letter for high oleic algae oil
Solazyme announced that the FDA has issued a favorable response to Solazyme’s notification which concludes that high-oleic algae oil is Generally Recognized as Safe as an ingredient in food products under the intended conditions of use. This No Questions letter will further pave the way for mainstream adoption of superior quality oleic algae oil with unprecedented functional, performance and nutritional benefits, enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients. Solazyme has also received FDA No Questions letters for the whole food ingredient products currently offered within the AlgaVia portfolio, including Whole Algal Protein and Whole Algal Flour.
February 19, 2015
14:34 EDTBGBunge repeats 2017 EPS target about $8.50
Subscribe for More Information
February 17, 2015
07:15 EDTBGConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use